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a  b  s  t  r  a  c  t
Background: Oxidative stress generated within inﬂammatory joints can produce autoim-
mune  phenomena and joint destruction. Radical species with oxidative activity, including
reactive nitrogen species, represent mediators of inﬂammation and cartilage damage.
Objectives: To assess serum nitric oxide as a marker of oxidative stress in Egyptian patients
with  rheumatoid arthritis and its relation to disease activity.
Methods: Eighty patients with rheumatoid arthritis were divided into 2 groups, according to
the  DAS-28 score: Group I: 42 patients with disease activity, and Group II: 38 patients with
no  disease activity. Forty age- and sex-matched individuals were included as control group
(Group III).  Routine laboratory investigations were done, and nitric oxide was measured
using Elisa. Hand plain radiographies were done for radiological status scoring using the
Sharp method.
Results: A comparison between nitric oxide in all three groups showed a highly signiﬁcant
difference (p < 0.001), signiﬁcantly higher levels were obtained among rheumatoid arthri-
tis  patients in comparison to controls, and higher levels were obtained in patients with
active disease (mean ± SD 82.38 ± 20.46) in comparison to patients without active disease
(35.53  ± 7.15). Nitric oxide in Group I showed a signiﬁcant positive correlation with morning
stiffness (r = 0.45), arthritis (r = 0.43), platelet count (r = 0.46), erythrocyte sedimentation rate
(r  = 0.83), C-reactive protein (r = 0.76) and Disease Activity Score (r = 0.85). Nitric oxide showed
a  signiﬁcant positive correlation (r = 0.43) with hand radiographies (Sharp score) in Group I.
Conclusion: There are increased levels of nitric oxide in the serum of patients with rheuma-
toid  arthritis. Nitric oxide correlates signiﬁcantly with disease activity, inﬂammatorymarkers and radiological joint status.
© 2014 Elsevier Editora Ltda. All rights reserved.DOI of original article: http://dx.doi.org/10.1016/j.rbr.2014.07.003.
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Níveis  de  óxido  nítrico  mais  elevados  estão  associados  à  atividade  da





r  e  s  u  m  o
Introduc¸ão: O estresse oxidativo produzido no interior de articulac¸ões inﬂamadas pode pro-
duzir fenômenos autoimunes e destruic¸ão articular. As espécies radicais com atividade
oxidativa, incluindo espécies reativas de nitrogênio, representam mediadores de inﬂamac¸ão
e  de lesão cartilaginosa.
Objetivos: Avaliar o óxido nítrico sérico como marcador de estresse oxidativo em pacientes
egípcios com artrite reumatoide e sua relac¸ão com a atividade da doenc¸a.
Métodos: Oitenta pacientes com artrite reumatoide foram divididos em dois grupos, de
acordo com a pontuac¸ão DAS28: Grupo I: 42 pacientes com doenc¸a ativa, e Grupo II: 38
pacientes com doenc¸a inativa. Quarenta indivíduos equiparados por idade e gênero foram
incluídos como grupo controle (Grupo III).  Foram realizados exames laboratoriais de rotina
e  o óxido nítrico foi medido usando Elisa. Radiograﬁas simples das mãos foram feitas para
a  pontuac¸ão do estado radiológico utilizando o método de Sharpe.
Resultados: A comparac¸ão do nível sérico de óxido nítrico entre os três grupos mostrou
uma diferenc¸a altamente signiﬁcativa (p < 0,001). Obtiveram-se níveis signiﬁcativamente
mais elevados entre os pacientes com artrite reumatoide em comparac¸ão com os con-
troles. Os níveis mais elevados foram obtidos em pacientes com a doenc¸a ativa (média ± DP
82,38 ± 20,46) em comparac¸ão com aqueles com a doenc¸a inativa (35,53 ± 7,15). O óxido
nítrico no Grupo I exibiu uma correlac¸ão positiva signiﬁcativa com a rigidez matinal (r = 0,45),
artrite (r = 0,43), contagem de plaquetas (r = 0,46), velocidade de hemossedimentac¸ão
(r  = 0,83), proteína C-reativa (r = 0,76) e Índice de Atividade de Doenc¸a (r = 0,85). O óxido nítrico
mostrou uma correlac¸ão positiva signiﬁcativa (r = 0,43) com as radiograﬁas das mãos (índice
de  Sharpe) no Grupo I.
Conclusão: Observa-se um aumento nos níveis séricos de óxido nítrico em pacientes com
artrite reumatoide. O óxido nítrico se correlaciona signiﬁcativamente com a atividade da
doenc¸a,  marcadores inﬂamatórios e estado radiológico das articulac¸ões.




















itric oxide (NO) is an endogenously produced small molecule
hat has critical roles in cellular signaling and is involved in
 variety of physiological processes. NO can have opposite
iological effects, depending upon various environmental and
athophysiological conditions.1
Oxidant stress generated within an inﬂammatory joint
an produce autoimmune phenomena and connective tis-
ue destruction within the synovium. Radical species with
xidative activity, which include reactive nitrogen species and
eactive oxygen species, represent the mediators and effectors
f cartilage damage.2
NO mediates many  different cell functions at the site of
ynovial inﬂammation, including signal transduction, mito-
hondrial function and apoptosis.3
NO has emerged as an important mediator in rheumatoid
rthritis (RA) synovium. Increased levels of NO in serum and
ynovial ﬂuid have been reported in patients with RA, anky-
osing spondylitis and osteoarthritis.4
The aim of this work is to assess NO level as a marker
f oxidative stress in Egyptian patients with RA and to
orrelate it with various disease parameters and disease
ctivity.Methods
In a cross sectional study, 80 patients with RA, diagnosed
according to the American College of Rheumatology/European
League against Rheumatism (ACR/EULAR) criteria,5 were
divided into 2 groups according to disease activity: Group I: 42
patients with disease activity, and Group II: 38 patients with no
disease activity. A third group was included: Group III: 40 age
and sex matched healthy individuals as control. All patients
were recruited from the Rheumatology Outpatient Clinic and
Internal Medicine Ward at Ain Shams University Hospital.
Informed consents were obtained from all participants, and
the study was approved by the Ain Shams Medical ethics
committee. The nature of the present study was explained,
and laboratory and radiological procedures represent standard
care posing no ethical conﬂicts. For all the patients, the follow-
ing were done:
I. Detailed medical history and thorough clinical and mus-
culoskeletal examination with assessment of disease activity
by using DAS28-ESR:6
Detailed history of disease duration and progression and
constitutional symptoms and signs of fever, weight loss and
fatigue were assessed, and a thorough musculoskeletal exam-
ination was performed.
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Disease activity was assessed using DAS28-ESR, and a
DAS28-ESR≤2.6 was considered indicative of no disease
activity.6
II. Laboratory investigations:
a) Routine laboratory investigations:
Complete blood count;
ESR in the ﬁrst hour, estimated by Western method;
CRP (mg/dL with titer).
b) Immunological investigations:
Rheumatoid factor: measured by using biotic RA factor
latex agglutination slide for the qualitative determination of
RF in serum.
c) Serum nitric oxide
NO was performed using ELISA (R&D Systems, Inc., Min-
neapolis, USA). This assay determines NO concentrations
based on the enzymatic conversion of nitrate to nitrite
by nitrate reductase. A preliminary deproteinization step
has been done using ultraﬁltration method, the ﬁlter used
was centristart 1, supplied by vivascience sartorius group
(www.sartorius.com). The reaction is followed by colorimet-
ric detection of nitrite as an azo dye product of the Griess
Reaction.7
III. Radiological investigations:
Plain X-ray hands and wrists for scoring the radiological
damage using Sharp method.8
Statistical  analysis
The collected data were coded, tabulated, and statistically
analyzed using SPSS program (Statistical Package for Social
Sciences) software version 17.0. Description of qualitative vari-
ables as number and percentage was done. Chi-square test
was used to compare qualitative variables. Fisher exact test
Table 1 – Comparison between Group I and Group II as regards
Gro
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Disease duration (years), mean (SD) 5
Clinical manifestations
Weight loss, n (%) 
Fatigue, n (%) 
Fever, n (%) 
Morning stiffness, n (%) 
Laboratory data
Hemoglobin, mean (SD) 11
Total leucocytic count, mean (SD) 7
Platelet, mean (SD) 382
Erythrocyte sedimentation rate (ESR), mean (SD) 60
C-reactive protein (CRP), mean (SD) 24
Rheumatoid factor (RF), n (%) 
There was a highly signiﬁcant difference (p < 0.001) between Group I and
(85%, 34% respectively). There was a highly signiﬁcant difference (p < 0.001
levels for both detected in Group I. 0 1 4;5 4(6):446–451
was used instead of chi-square test when one expected cell
or more  ≤ 5. Unpaired t-test was used to compare two inde-
pendent groups as regards quantitative variables. Spearman
& Person Correlation coefﬁcient rank test was used to rank
different variables against each other’s positively or inversely.
P-value = level of signiﬁcance, where p > 0.05 = not signiﬁcant
(NS), p < 0.05 = signiﬁcant (S), and p < 0.001 = highly signiﬁcant
(HS).
Results
In Group I, 23 were females, and 19 were males. Their age
ranged from 27 to 63 years with mean ± SD 48.78 ± 12.41,
and disease duration 5.48 ± 6.63 years. In Group I, 21 were
females, and 17 were males. Their age ranged from 28 to
65 years with mean ± SD 44.10 ± 10.54, and disease duration
6.59 ± 5.81 years. There was no signiﬁcant difference between
both groups as regards gender, age or disease duration.
Fatigue and morning stiffness were signiﬁcantly more  fre-
quent in Group I than in Group II patients (p < 0.001). Patients
from Group I also had signiﬁcantly higher ESR and CRP values
than Group II patients (p < 0.001) (Table 1).
There was a signiﬁcant difference between Group I and
Group II as regards X-ray Sharp score (Table 2).
On comparing NO level among the three groups, signif-
icantly higher levels were detected among RA patients in
comparison to controls, with highest levels obtained among
RA patients with disease activity (Group I) (Table 3).
Correlation between serum NO level and various disease
parameters in Group I showed a signiﬁcant positive correlation
(p < 0.05) with morning stiffness, arthritis and platelet count,
and a highly signiﬁcant positive correlation (p < 0.001) with dis-
ease activity, ESR and CRP. (Table 4); furthermore, NO showed
 demographic, clinical and laboratory data.
up I Group II p
.78 (12.41) 44.10 (10.54) > 0.05
19(45) 17(45) > 0.05
23(55) 21(55) > 0.05
.48 (6.63) 6.59 (5.81) > 0.05
16 (38) 15 (39) > 0.05
21(50) 10 (26) < 0.001
4 (10) 0 (0) > 0.05
36 (85) 13 (34) < 0.001
.06 (1.64) 11.87 ± 1.61 > 0.05
.68 (2.61) 7.12 ± 2.38 > 0.05
.81 (102.24) 261.14 ± 74.37 < 0.05
.69 (24.32) 19.76 ± 5.29 < 0.001
.48 (12.64) 8.52 ± 3.01 < 0.001
36 (86) 30 (79) > 0.05
 II as regards fatigue (50%, 26% respectively) and morning stiffness
) between Group I and II as regards ESR and CRP protein with higher
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Table 2 – Comparison between group I and II as regards
X-ray Sharp score.
Sharp score Group I Group II p
n % n %
0 2 5 3 8 < 0.05
1 4 10 16 42 < 0.001
2 6 14 11 29 < 0.01
3 18 43 5 13 < 0.001
4 10 23 2 5 < 0.001
5 2 5 0 0 < 0.01
Table 3 – Comparison between Groups I, II, and III as
regards serum NO.
Serum NO Group I Group II Group III p-value
Mean ± SD 82.38 ± 20.46 35.53 ± 7.15 14.25 ± 4.09 < 0.001
Signiﬁcantly higher levels of NO were detected among RA patients
in comparison to controls with highest levels obtained among RA
patients with disease activity (Group I).
Table 4 – Correlation between serum NO level and
various disease parameters in Group I.
Variable r p-value
Age 0.231 > 0.05
Disease duration -0.252 > 0.05
Morning stiffness 0.453 < 0.05
Arthritisa 0.432 < 0.05
Platelet 0.458 < 0.05
ESR 0.832 < 0.001
CRP 0.763 < 0.001
Disease activity 0.846 < 0.001
ESR, erythrocyte sedimentation rate; CRP, C-reactive protein.
NO showed a signiﬁcant positive correlation (p < 0.05) with morn-
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Figure 1 – Correlation between serum NO level and handpositive correlation (p < 0.001) with disease activity, ESR and CRP.
a 28-tender and/or swollen joint count.
 signiﬁcant positive correlation with X-ray hand Sharp score
p < 0.05) in Group I (Fig. 1). No signiﬁcant correlation between
O and X-ray hand Sharp score in Group II could be detected.
iscussion
nﬂammation and tissue injury related to oxidative stress has
een implicated in the pathogenesis of RA. Oxidative stress
nd decreased antioxidant status are the hallmarks in patients
f RA as observed in recent years.9 NO-dependent tissue injury
as been implicated in a variety of rheumatic diseases, includ-
ng RA.10
The present study assesses NO level as a marker of oxida-
ive stress in patients with RA and its relation to disease
ctivity. The study included 80 patients with RA, 42 patients
ith disease activity (Group I) and 38 without activity (Group
I).
Patients with disease activity complained signiﬁcantly
ore  (p < 0.001) of morning stiffness and fatigue as compared
o those without disease activity. This is most likely due to
he fact that clinical manifestations, such as morning stiff-X-ray Sharp score in Group I. NO showed a signiﬁcant
positive correlation with X-ray hand Sharp score (p < 0.05).
ness, have long been associated with disease activity in RA,
and so it is expected that signiﬁcantly higher values are to be
obtained in active RA patients.11
In the present study, both ESR and CRP were signiﬁcantly
higher in the active group (p < 0.001). Although CRP appears to
be the better test regarding measurement of the acute phase,
yet because ESR is sensitive to immunoglobulins and RF, it may
measure general severity better than CRP, even though it is a
poorer measure of inﬂammation.12 In a study to assess clinical
utility of measurements of CRP and ESR in evaluating patients
with RA, it was found that both ESR and CRP were signiﬁcant
predictors of swollen joint count (p < 0.001 for each).13
In this study, comparison between serum NO in all three
groups showed a highly signiﬁcant difference (p < 0.001),
where signiﬁcantly higher levels were obtained among RA
patients than controls and even higher levels were obtained
in active RA patients (mean ± SD 82.38 ± 20.46), than the
inactive group (mean ± SD 35.53 ± 7.15). Serum NO level in
Group I showed a signiﬁcant positive correlation with morn-
ing stiffness (r = 0.45), arthritis (r = 0.43) and platelet count
(r = 0.46), and a highly signiﬁcant positive correlation was
found between NO and each of ESR (r = 0.83) and CRP (r = 0.76),
as well as DAS (r = 0.84).
On comparison between both groups as regards radiologi-
cal damage using Sharp score, there was a highly signiﬁcant
difference between both groups (p < 0.001). NO levels showed a
signiﬁcant positive correlation (r = 0.43) with X-ray hand Sharp
score only in Group I, yet no correlation between NO and X-
ray hand Sharp score in Group II could be detected. Studies
have demonstrated a longitudinal relationship between dis-
ease activity and radiographic status.14 A study concluded that
the level of disease activity, as well as the duration of remis-
sion, affect subsequent progression of radiographic damage
in RA.15 Consequently, since disease activity may be one of
the drivers of joint damage and radiographic progression in
RA, it would be expected that since NO correlates with dis-
ease activity, it would also correlate with radiographic damage
in patients with active disease, as has been detected in the
present study. In contrast, however other studies have con-
cluded that, despite clinical improvement and remission in
patients with active RA, the radiographic progression con-
tinues over time because of the underlying inﬂammatory
process.16
In line with this study, several studies have proved
increased serum NO level in RA patients compared to
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control groups,17,18 One study suggested that nitrate and
nitrite production is enhanced in patients with RA compared
with healthy subjects.4
NO has been shown to regulate T-cell functions under phys-
iological conditions, but overproduction of NO may contribute
to T-lymphocyte dysfunction. The increase in NO production
in RA patients may be due to the increase in NO synthase
activity.19
Similarly, a signiﬁcant correlation between serum nitrate
concentrations and number of tender joints, number of
swollen joints, DAS score and CRP level has been detected.20
The results suggest that these ﬁndings can serve as a reliable
parameter of disease activity in patients with RA.
Although it has been suggested that reactive nitrogen
species are produced within the inﬂamed joints of RA patients
and that the levels correlate directly with disease activity,21
several studies concluded that NO level did not correlate with
ESR neither with CRP, and that there was a non-signiﬁcant cor-
relation between the serum levels of each of nitrogen species
and the duration of disease or ESR as a marker of disease
activity.18,22
Oxidative stress generated in an inﬂamed joint can con-
tribute to autoimmune phenomenon and connective tissue
destruction in RA, and the production of NO and prostaglandin
E2 from articular chondrocytes probably contribute to the car-
tilage destruction seen in arthritis.23 In the present study, a
signiﬁcant positive correlation was detected between serum
NO level and radiological status in both RA groups, suggest-
ing a role for NO not only in disease activity, but also in joint
damage.
In the present cross sectional study conducted on a cohort
of Egyptian RA patients, NO was not only detected with sig-
niﬁcantly higher levels in active RA patients, but correlated
signiﬁcantly with various disease parameters and activity. The
study also included radiological assessment of X-ray hands
using Sharp score, which also showed signiﬁcant correlation
with NO levels. However, mainly due to the limitation imposed
by its cross sectional design, the results of the study could
either demonstrate a causative effect of NO or simply reﬂect
the inﬂammatory status of disease activity.
Finally, it can be concluded from the present study that
there is an increased level of NO in the serum of RA patients
and that NO level correlates signiﬁcantly with disease activ-
ity as well as radiological joint status. This could suggest the
involvement of free radicals not only in the inﬂammatory pro-
cess of RA, but also in the joint destruction. New therapeutic
protocols based on correcting oxidative stress levels may prove
effective in restricting disease progression and limiting defor-
mities.
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